Article ; Online: Long term follow-up of refractory/relapsed acute myeloid leukemia patients treated with the FLAG-Ida regimen as bridge therapy to allotransplantation: 10-year results from a single centre experience.
2023 Volume 129, Page(s) 107069
MeSH term(s) | Humans ; Bridge Therapy ; Follow-Up Studies ; Leukemia, Myeloid, Acute/drug therapy ; Idarubicin ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cytarabine ; Granulocyte Colony-Stimulating Factor ; Vidarabine ; Recurrence |
---|---|
Chemical Substances | Idarubicin (ZRP63D75JW) ; Cytarabine (04079A1RDZ) ; Granulocyte Colony-Stimulating Factor (143011-72-7) ; Vidarabine (FA2DM6879K) |
Language | English |
Publishing date | 2023-03-24 |
Publishing country | England |
Document type | Letter |
ZDB-ID | 752396-8 |
ISSN | 1873-5835 ; 0145-2126 |
ISSN (online) | 1873-5835 |
ISSN | 0145-2126 |
DOI | 10.1016/j.leukres.2023.107069 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1321: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.